Quality control the AI way | Partner voice | AI-eager doctors, AI-reticent buyers, AI cost worriers, more

News You Need to Know Today
View Message in Browser

Quality control the AI way | Partner voice | AI-eager doctors, AI-reticent buyers, AI cost worriers, more

Tuesday, April 22, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Nabla Logo ●  Fellow

artificial intelligence AI in healthcare

7 pointers for AI-driven quality control in medicine

By automating repetitive tasks and ensuring consistent “QC,” well-deployed AI not only unburdens healthcare professionals but also sets new standards for efficiency and reliability in medical practice. 

At the same time, AI’s inherent challenges to trust, ethics, privacy and generalizability continue to vex proponents of widespread adoption.

These sorts of limitations “highlight the need for robust QC measures to ensure AI systems are both reliable and equitable,” write researchers from the College of Medicine at the Catholic University of Korea in Seoul. Their paper, published April 16 in Life, an open-access journal of the Multidisciplinary Digital Publishing Institute, offers guidelines for addressing such concerns in the context of continuous quality control. 

Among their prescriptions are these seven: 

1. Ensure the quality and standardization of medical data. 

To enhance AI reliability, medical institutions should use high-quality, well-annotated datasets and follow standardized data processing protocols, the authors suggest. Additionally, they write: 

‘Datasets must be regularly updated and validated to maintain accuracy and relevance in clinical applications.’

2. Automate image quality assessment and quality assurance systems. 

Advanced AI models can detect errors, refine image segmentation and minimize diagnostic inconsistencies, corresponding author Tae Jung Kim and co-authors write, adding that these tasks can help enhance diagnostic accuracy. More: 

‘Implementing real-time feedback mechanisms will further improve the precision of medical imaging interpretation.’

3. Let AI play a vital role in surgical guidance and treatment planning. 

AI-assisted systems, the authors note, can identify anatomical structures with high precision, provide real-time monitoring during procedures and reduce surgical errors. 

‘By integrating AI into personalized treatment planning, healthcare providers can predict patient outcomes more effectively.’

4. Make sure AI adoption complies with ethical and legal regulations. 

“Strict measures should be taken to protect patient data privacy under laws such as the General Data Protection Regulation (GDPR) and the Health Insurance Portability and Accountability Act (HIPAA),” the authors comment. “Additionally, AI should be explainable (XAI) so that medical professionals can understand its decision-making process.” 

‘Establishing clinical validation procedures is also necessary to ensure AI aligns with standard medical practices.’

5. Continuously evaluate and refine AI models to improve their performance. 

Regular retraining and validation of AI models with updated datasets will enhance their reliability, Prof. Kim and colleagues point out. 

‘Creating a feedback loop with healthcare professionals can further refine AI models and optimize their effectiveness in clinical practice.’

6. Integrate AI as a decision-support tool, not as an alternative to human expertise.  

Healthcare professionals should receive adequate training to utilize AI effectively, the authors underscore. 

‘Usability studies should be conducted to gather feedback from medical practitioners, ensuring that AI systems remain practical and user-friendly in real-world applications.’

7. Carefully assess the financial impact of AI implementation in healthcare. 

“Hospitals and clinics should conduct cost-benefit analyses to determine whether AI-driven automation reduces operational costs and enhances efficiency.” 

‘Furthermore, AI adoption should directly contribute to improved patient outcomes and overall healthcare quality.’

The authors conclude that, by combining its inherent strengths with these targeted QC strategies, AI “has the potential to overcome its current limitations and further revolutionize medical practice.”

More: 

‘As healthcare continues to evolve, embracing AI’s transformative potential while addressing its challenges through thoughtful guidelines will be key to delivering safer, more personalized care for patients worldwide.’

Read the whole thing.

 

 Share on Facebook Share on Linkedin Send in Mail

The Latest from our Partners

Meet Nabla at Becker’s Annual Meeting (April 28 - May 1st, Chicago, IL)
Looking for both ambient note generation and dictation—in one AI assistant? Nabla is the only AI assistant that does both, seamlessly.
📍 Visit booth 10F for a demo - you’ll see why Nabla is changing the way care teams work.

 Share on Facebook Share on Linkedin Send in Mail
AI physician leader

Newswatch: AI-eager doctors, AI-reticent buyers, AI cost worriers, more

Buzzworthy developments of the past few days.

  • Nearly 95% of the world’s healthcare providers are keen on AI. More to the point, they would have no qualms about integrating the technology as long as they’re sure it would prove practice-appropriate. So found market researchers commissioned by Johnson & Johnson. The team surveyed more than 950 HCPs as well as more than 11,400 members of the general public across 11 countries. J&J also sought and received quotes from some individual physicians. A common theme to emerge from both arms of the project was the aging of the world’s population. For example, orthopedic surgeon Kevin Perry of the Mayo Clinic noted that AI and other emerging technologies “not only enhance the quality of care but also allow us to address the unique challenges that come with an aging population, such as joint replacements and more complex procedures.” Perry added that he sees “immense value” in tapping technology to help reduce burnout by allowing providers to focus on what truly matters—patient care. “By continuing to embrace robotics and the power of data and technology,” Perry says, “we can build a more sustainable healthcare system that meets the needs of both patients and providers alike.” 
     
  • Meanwhile, buyers of healthcare AI report that less than a third of their AI pilots, 30%, reach production. This finding is from Bessemer Venture Partners, which surveyed 400+ purchasers across provider, payer and pharma segments. The researchers found the major pinch points are security, data readiness, integration costs and limited in-house expertise. Commenting on the findings, Bessemer analysts advise AI startups to rethink their go-to-market strategy as they build market traction and prove results with peer healthcare organizations. “Healthcare buyers want innovation but are still risk-averse,” the analysts observe. “It’s the classic catch-22: You need social proof to sell, but you can’t get social proof until you do.”
     
  • Might healthcare AI raise costs as well as quality? One physician and AI expert worries about that. AI and other emerging technologies “don’t come free, and the more you use them, the more they cost,” says Ronald Rodriguez, MD, PhD, director of UT-San Antonio’s dual MD/MS in AI program. “All the tech entrepreneurs are relying on that [scenario]—it’s their business model.” Rodriguez made the remarks to Medical Economics, which is out with a special issue devoted to AI. In the cover feature, a handful of physicians tell how they’re using AI in day-to-day practice. The full issue is posted as an ezine here
     
  • In medicine’s next chapter, AI literacy will separate physician leaders from peer followers. This will be so for three reasons—time leverage, income diversification and career control. Physician blogger Peter Kim, MD, makes the case at the website he founded, Passive Income MD. “When you understand emerging technologies, you position yourself as someone who can lead innovation, not be replaced by it,” he writes in an April 21 post. “You also stay relevant, especially as patients increasingly expect more tech-savvy care.” Hear him out on this. 
     
  • Consider what AI can learn from EHRs. Two AI-savvy radiologists encourage all healthcare AI stakeholders to look back at, in particular, the Meaningful Use era. “The MU program utilized early incentives that declined over time (eventually penalties replaced incentives),” remind Drs. Richard Heller and Nina Kottler, both of 50-state, private equity-backed Radiology Partners. “Using a similar approach of front-loaded, declining incentives, an AI-focused program could help accelerate adoption and implementation, ensuring interoperability and promoting responsible use.” Given how long it’s been since Meaningful Use was a hot topic, they make a surprisingly compelling case. MedPage Today published it April 19. 
     
  • At one point, employees at Johnson & Johnson were pursuing almost 900 AI use cases. Leaders at the healthcare conglomerate waited patiently for the shakeout they knew would come due to redundancies, poor algorithmic performers and such. As the period rolled along, the company found 10% to 15% of test adoptions were driving 80% of successes. J&J’s CIO, Jim Swanson, tells the Wall Street Journal the company is now tracking progress across three measurable performance indicators—successful deployments, broad adoptions and business outcomes. “We had the right plan three years ago [with the 900 tryouts], but we matured our plan based on three years of understanding,” he says. “This is the better way to run now.”
     
  • More than 16,500 individuals in the U.K. have been waiting more than 18 months for mental healthcare. By comparison, only 2,000 are waiting for elective physical health treatments. No wonder young people are giving AI therapists a go. Some experts worry about the trend. Technology as the go-to answer for this problem “can fuel self-obsession because [the patient is] generating all the questions,” warns integrative therapist Billie Dunlevy in coverage by The Times of London. “What true psychotherapy offers is someone being in relation with you and reflecting back what they see or how they experience you.”
     
  • Meet 13 healthcare AI companies to watch the rest of this year. Listing the hotties based mainly on info from Gartner in alphabetical order, TechTarget starts with Arcadia, Amazon Web Services and Cleerly. See who the other 10 are right here
     
  • Recent research in the news: 
     
  • FDA approval activity:
     
  • Funding news of note:
     
  • From AIin.Healthcare’s news partners:
     
 Share on Facebook Share on Linkedin Send in Mail

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare